CoChat

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Dyskeratosis Congenita

Open access
Gadalla, Shahinaz M., Sales-Bonfim, Carmem, Carreras, Jeanette, Alter, Blanche P., Antin, Joseph H., Ayas, Mouhab, Bodhi, Prasad, Davis, Jeffrey, Davies, Stella M., Deconinck, Eric, Deeg, H. Joachim, Duerst, Reggie E., Fasth, Anders, Ghavamzadeh, Ardeshir, Giri, Neelam, Goldman, Frederick D., Kolb, E. Anders, Krance, Robert, Kurtzberg, Joanne, Leung, Wing H., Srivastava, Alok, Or, Reuven, Richman, Carol M., Rosenberg, Philip S., Toledo Codina, Jose Sanchez de, Shenoy, Shalini, Socié, Gerard, Tolar, Jakub, Williams, Kirsten M., Eapen, Mary, Savage, Sharon A. · 2013 · Biology of Blood and Marrow Transplantation
Cited by 131

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

We describe outcomes after allogeneic transplantation in 34 patients with dyskeratosis congenita who underwent transplantation between 1981 and 2009. The median age at transplantation was 13 years (range, 2 to 35). Approximately 50% of transplantations were from related donors. Bone marrow was the predominant source of stem cells (24 of 34). The day-28 probability of neutrophil recovery was 73% and the day-100 platelet recovery was 72%. The day-100 probability of grade II to IV acute GVHD and the 3-year probability of chronic graft-versus-host disease were 24% and 37%, respectively. The 10-year probability of survival was 30%; 14 patients were alive at last follow-up. Ten deaths occurred within 4 months from transplantation because of graft failure (n = 6) or other transplantation-related complications; 9 of these patients had undergone transplantation from mismatched related or from unrelated donors. Another 10 deaths occurred after 4 months; 6 of them occurred more than 5 years after transplantation, and 4 of these were attributed to pulmonary failure. Transplantation regimen intensity and transplantations from mismatched related or unrelated donors were associated with early mortality. Transplantation of grafts from HLA-matched siblings with cyclophosphamide-containing nonradiation regimens was associated with early low toxicity. Late mortality was attributed mainly to pulmonary complications and likely related to the underlying disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbmt.2013.05.021

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 131

Metadata

Authors
Gadalla, S. M., Sales-Bonfim, C., Carreras, J., Alter, B. P., Antin, J. H., Ayas, M., Bodhi, P., Davis, J., Davies, S. M., Deconinck, E., Deeg, H. J., Duerst, R. E., Fasth, A., Ghavamzadeh, A., Giri, N., Goldman, F. D., Kolb, E. A., Krance, R., Kurtzberg, J., Leung, W. H., Srivastava, A., Or, R., Richman, C. M., Rosenberg, P. S., Toledo Codina, J. S. D., Shenoy, S., Socié, G., Tolar, J., Williams, K. M., Eapen, M., & Savage, S. A.
Venue
Biology of Blood and Marrow Transplantation
Publisher
Elsevier BV
Published
2013-08
Volume
19
Issue
8
Pages
1238-1243
ISSN
1083-8791 (ISSN-L)
OpenAlex
W2028754058
Cited by
131
References
5
FWCI
8.75
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Dyskeratosis Congenita. https://app.cochat.ai/papers/10.1016/j.bbmt.2013.05.021
The paper
Gadalla, S. M., Sales-Bonfim, C., Carreras, J., Alter, B. P., Antin, J. H., Ayas, M., Bodhi, P., Davis, J., Davies, S. M., Deconinck, E., Deeg, H. J., Duerst, R. E., Fasth, A., Ghavamzadeh, A., Giri, N., Goldman, F. D., Kolb, E. A., Krance, R., Kurtzberg, J., . . . Savage, S. A. (2013). Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Dyskeratosis Congenita. Biology of Blood and Marrow Transplantation. https://doi.org/10.1016/j.bbmt.2013.05.021

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.